Press Release

Toft Group CEO and Founder Robin Toft Joins Syapse Board of Directors

Seasoned Biotech Executive Brings Deep Insight into Life Sciences Industry and Passion for Precision Medicine

SAN FRANCISCO, Calif., October 28, 2020 — Syapse®, a real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health NetworkTM, announced today that Robin Toft, founder and CEO of Toft Group, a ZRG Company, has joined the Company’s board of directors. Toft combines more than two decades of deep expertise in the life sciences industry, including a passion for building game-changing leadership teams at precision health and oncology companies. She founded Toft Group in 2010 to support the life sciences and healthcare industry in building successful leadership teams while overcoming unconscious bias, specifically in top role placements of women and ethnically diverse candidates.

“It’s time for us to deliver on the promise of precision medicine so every cancer patient is getting the best care possible,” Toft said. “At Syapse, that promise harnesses the power of real-world evidence to enable oncology teams to gather and synthesize the data they need to make targeted treatment decisions. I am looking forward to working with the Syapse Board and leadership team especially as the company moves into their next phase of growth and development.”

Toft’s appointment to the Syapse Board follows key milestone announcements including new partnerships with health systems that have joined Syapse’s Learning Health Network, another round of equity financing, as well as an expanded research collaboration with the U.S. Food and Drug Administration (FDA).

“Robin’s long-standing relationships with strategic pharma partners, coupled with her ability to build and lead diverse executive teams, is uniquely suited to support Syapse as we build on our recent progress and continue to pursue our mission of delivering the best care to every cancer patient,” said Ken Tarkoff, chief executive officer of Syapse. “It’s a pleasure to welcome Robin to the Syapse Board, and I know her reputation for building innovative companies will be a great asset to us as we navigate new partnership opportunities in the life sciences industry.”

About Syapse

Syapse works with leading health systems, life sciences companies, and regulators to explore opportunities to use real-world evidence to improve the outcomes of cancer patients. By bringing these organizations together into the Syapse Learning Health NetworkTM, Syapse has built one of the world’s largest networks with a goal to improve outcomes in cancer care through improved precision medicine. Syapse and its partners are working towards a future in which all cancer patients have access to the quality of care they need.

 

About the Syapse Learning Health Network™

This international network of healthcare providers enables improved cancer care by sharing real-world data to support clinical decisions and by fostering collaborations among participants. Healthcare providers, including doctors and nurses, share and learn which cancer treatments produced the best real-world outcomes in clinically and molecularly similar patients. Researchers learn from real-world clinical, molecular, treatment and outcomes data. These collaborations are enabled by a secure platform of shared de-identified data that is standardized and normalized across the Learning Health Network and complies with all applicable federal and state data privacy protection regulations.

 

###

Syapse Contacts

David Pomerantz 

david.pomerantz@syapse.com

Denise Powell (Media)

denise@redhousecomms.com